conclusion

We propose a decisional tree to  determine the suitability of different injectable cements according to specific pathologies (see discussion).  The recent development of PMMAs and the market introduction of new bone cements (composite cements and calcium phosphate cements) allow physicians to choose the best material for the treatment of  different lesions causing vertebral pain.  Further study and progress will be required to allow better management of spinal pain due to vertebral lesions.  A larger selection of cements dedicated to specific indications will optimize the future role of cements in the application of percutaneous vertebroplasty.